Oric Pharmaceuticals, Inc. (ORIC): Operating Cash Flow
-$110.97M
Year ended 2025-12-31
-$111.64M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$110.97M | n/m | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | -$112.66M | n/m | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | -$85.69M | n/m | 2025-02-18, From 2023-01-01 |
| 2022-12-31 | -$75.14M | n/m | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | -$59.54M | n/m | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | -$45.27M | n/m | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | -$23.53M | n/m | 2022-03-21, From 2019-01-01 |
| 2018-12-31 | -$20.68M | n/a | 2021-03-23, From 2018-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | 2025-12-31 | -$110.97M | n/m |
| Alumis Inc. (ALMS) | 2025-12-31 | -$369.52M | n/m |
| Nkarta, Inc. (NKTX) | 2025-12-31 | -$88.70M | n/m |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | $45.59M | n/m |
| Harrow, Inc. (HROW) | 2025-12-31 | $43.86M | n/m |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | -$138.89M | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $127.04M | +22.7% |
| Erasca, Inc. (ERAS) | 2025-12-31 | -$95.45M | n/m |
| MoonLake Immunotherapeutics (MLTX) | 2025-12-31 | -$196.01M | n/m |
Compare ORIC, ALMS, NKTX, STOK side by side · Screen every company in Pharmaceutical Preparations ↗